Pascal Soriot says 2020 approval still possible for AstraZeneca's Covid-19 vaccine as the world awaits the safety board's decision
Moderna was the first company to put a vaccine candidate into humans, but for much of the pandemic it was AstraZeneca and their academic partners at Oxford University putting out the most aggressive timelines. They signed deals with the UK promising to supply doses as early as September and Sarah Gilbert, the vaccine’s academic architect, talked, albeit cautiously, about getting efficacy data by that time.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
